EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Unlocking Opportunity: Dominate the Cancer Vaccine Market with Confidence Now Available. Tracks 960+ Organizations and 2,100+ Drugs Across the Full Cancer Vaccine Pipeline
BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar
This $26 Billion Biotech Name Is Ripe for a Covered-Call Trade
Pfizer (PFE) Stock Looks Overvalued After Updated COVID Vaccine Approval
BioNTech (BNTX) Stock Looks Above Fair Value As Shares Fell 70%
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
Is BioNTech Stock a No-Brainer Buy on the Dip?
BioNTech (BNTX) Halts Cancer Trial, Is The 15% Undervaluation Still Credible?
Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus
BioNTech (NASDAQ:BNTX) Given New $136.00 Price Target at Canaccord Genuity Group - Markets Daily
Pfizer Inc. (NYSE:PFE) Receives $28.28 Consensus Target Price from Analysts - Markets Daily
Canaccord Genuity Group Cuts BioNTech (NASDAQ:BNTX) Price Target to $136.00 - Stock Observer
Headlands Technologies LLC Takes Position in BioNTech SE Sponsored ADR $BNTX - Daily Political
Investors Purchase High Volume of BioNTech Put Options (NASDAQ:BNTX)
Pfizer (NYSE:PFE) Stock Price Down 1% - Here's What Happened - Markets Daily
Freestone Grove Partners LP Boosts Position in Pfizer Inc. $PFE
Van ECK Associates Corp Has $399.36 Million Stock Holdings in Pfizer Inc. $PFE - Stock Observer
Freestone Grove Partners LP Buys 254,644 Shares of Pfizer Inc. $PFE - Daily Political
BioNTech (BNTX) Ended A Phase 2 Colorectal Cancer Trial
BioNTech Kills a Cancer Trial Roche Helped Build
BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax - Update | Morningstar
BioNTech Target of Unusually Large Options Trading (NASDAQ:BNTX) - Zolmax
Stock Traders Buy Large Volume of Put Options on BioNTech (NASDAQ:BNTX)
FDA approves updated COVID vaccine for seniors and high-risk adults
BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast
Markets News, Aug. 28, 2026: Indexes Close Higher for Week; Marvell Weighs on Tech Stocks; Bond Yields Rise After Warsh Speech
Best Biotech Stocks To Research - August 28th - Daily Political
The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why
FDA approves updated Covid-19 vaccines
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech | Morningstar
BioNTech (BNTX) Rallied on Moderna's Win. Does a Competitor's Success Validate its Oncology Pipeline?
Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips
$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, Challenges
Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.
Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips
BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing
BioNTech (BNTX) Is Up 25.2% After First-in-Class Pumitamig Plus B7H3 ADC Lung Data - What's Changed
BioNTech (BNTX) Stock Looks Fully Priced As It Rebounds From A 67% Fall
BioNTech (BNTX) Presents New Lung Cancer Data, Is The Stock Already Fully Valued?
Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session
BioNTech (NASDAQ:BNTX) Shares Up 7.4% - Here's What Happened - Daily Political
Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips
Flossbach Von Storch SE Makes New Investment in BioNTech SE Sponsored ADR $BNTX
BioNTech Sees Unusually High Options Volume (NASDAQ:BNTX)
BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's Why
Moderna Rockets 93%, Merck Jumps 7% as Melanoma Therapy Meets Primary Goal in Phase 3 Trial
Biotech Stocks To Keep An Eye On - August 19th - Daily Political
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Brokerages
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives $127.81 Average Target Price from Analysts - Daily Political
BioNTech's oncology pivot comes with a new CEO
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Recommendation of "Moderate Buy" by Brokerages
BioNTech Just Named a New CEO. Here's What Guido Oelkers' Appointment Means for the Stock.
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Bios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance
Bank of America Corp DE Raises Stake in BioNTech SE Sponsored ADR $BNTX
Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell - Stock Observer
Assenagon Asset Management S.A. Makes New $39.38 Million Investment in BioNTech SE Sponsored ADR $BNTX
BioNTech News
SK Hynix Stock Price Forecast 2026–2030: Can Memory Inventories Below 10 Days Push SKHY Above $185?
SpaceX Stock Price Prediction 2026, 2027, 2030 & 2040: How High Can SPCX Go?
Cardano ADA Price Prediction 2026, 2027 & 2030: Is ADA Undervalued?
Crude Oil Price Forecast 2026, 2027 and 2030: Can Brent Reclaim $100 as Hormuz Risks Rise?
Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?
Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?
Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far
Latest news
Show more
Gold Price Today, September 8: Gold Rebounds Above $4,420 as US Dollar Weakens
Oil Price Today Nears $100 as US-Iran Tanker Attacks Threaten Hormuz Supply
Copper Price Hits Record $14,533 as Tariff Uncertainty Tightens Global Supply
GameStop Earnings Date September 8: Can Investment Gains Revive GME Stock Despite Falling Sales?
Gold Price Forecast This Week: Will US CPI Push XAU/USD Below $4,400 or Back Above $4,500?
